You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00527-2803


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00527-2803

Drug Name NDC Price/Unit ($) Unit Date
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.27269 EACH 2024-12-18
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.33369 EACH 2024-11-20
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.38033 EACH 2024-10-23
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.85770 EACH 2024-09-18
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.20537 EACH 2024-08-21
VARDENAFIL HCL 20 MG TABLET 00527-2803-32 2.02174 EACH 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00527-2803

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
VARDENAFIL HCL 20MG TAB AvKare, LLC 00527-2803-32 30 408.23 13.60767 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00527-2803 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 0527-2803

Introduction

The National Drug Code (NDC) 0527-2803 is assigned to Vardenafil Hydrochloride tablets, a prescription medication used to treat erectile dysfunction. This analysis will delve into the market dynamics, price trends, and projections for this specific drug.

Market Overview

The US pharmaceutical market, which includes drugs like Vardenafil Hydrochloride, is projected to grow significantly over the next few years. Here are some key points:

  • Market Growth: The US pharmaceutical market is expected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].
  • Generic and Biosimilar Impact: The market is influenced by the increasing approval and adoption of generic drugs and biosimilars. This segment is expected to see modest revenue growth, despite mid-single-digit percent annual price erosion in the generic drug industry[3].

Drug Specifics

  • Vardenafil Hydrochloride: This drug is a generic version of Levitra, used to treat erectile dysfunction. The NDC 0527-2803-32 corresponds to a package of 30 tablets in one bottle, labeled by Lannett[5].

Price Trends

  • Generic Drug Pricing: Generic drugs, including Vardenafil Hydrochloride, often experience price erosion over time. In 2022, the median price increase for generic drugs was 19.9%, but this can vary widely. For instance, some generic drugs saw significant price increases, such as a 2,527% increase for a generic naproxen[2].
  • Competition and Pricing: The generic drug market is highly competitive, which can lead to price reductions. However, the pricing of Vardenafil Hydrochloride can also be influenced by factors such as production costs, regulatory requirements, and market demand.

Regulatory and Transparency Factors

  • Price Transparency: Initiatives like the Oregon Prescription Drug Price Transparency Act aim to provide accountability by disclosing specific pricing information from pharmaceutical manufacturers. This transparency can impact pricing strategies and consumer trust[2].
  • Regulatory Compliance: Pharmaceutical companies must comply with FDA regulations, which can affect pricing and market entry. NDC numbers play a crucial role in this compliance, ensuring that drugs meet quality and safety standards[1].

Market Projections

  • Price Stability: Given the competitive nature of the generic drug market, prices for Vardenafil Hydrochloride are likely to remain stable or experience modest reductions over the next few years.
  • Volume and Revenue: Despite potential price erosion, the overall revenue for Vardenafil Hydrochloride could remain stable or increase slightly due to growing demand for erectile dysfunction treatments and the expanding pharmaceutical market[4].

Key Factors Influencing Pricing

  • Production Costs: Increases in raw material costs or manufacturing expenses can lead to higher prices.
  • Market Demand: Growing demand for erectile dysfunction treatments can support stable or increasing prices.
  • Regulatory Changes: Changes in regulatory requirements or transparency laws can impact pricing strategies and consumer perceptions[2].

Best Practices for Pharmaceutical Companies

  • Utilizing NDC Numbers: Accurate use of NDC numbers can help in tracking, inventory management, and regulatory compliance, which are crucial for maintaining competitive pricing and market presence[1].
  • Data-Driven Insights: Analyzing NDC data can provide valuable insights into market trends, patient preferences, and prescribing patterns, helping companies to develop targeted marketing strategies and optimize pricing[1].

Conclusion

The market for Vardenafil Hydrochloride, identified by the NDC 0527-2803, is influenced by broader trends in the US pharmaceutical market, including the growth of generic and biosimilar drugs. While price erosion is a common phenomenon in the generic drug sector, the demand for erectile dysfunction treatments and the overall growth of the pharmaceutical market suggest that prices for this drug will likely remain stable or experience modest adjustments.

Key Takeaways

  • The US pharmaceutical market is projected to grow significantly by 2030.
  • Generic drugs, including Vardenafil Hydrochloride, may experience price erosion but can maintain stable revenue due to growing demand.
  • Regulatory transparency and compliance are crucial for pricing strategies.
  • NDC numbers play a vital role in tracking, inventory management, and regulatory compliance.

FAQs

Q: What is the significance of NDC numbers in the pharmaceutical industry? A: NDC numbers provide a standardized way to identify and track medications, ensuring accurate tracking, inventory management, and regulatory compliance. They also contribute to improved patient care and optimized supply chains[1].

Q: How does the generic drug market impact the pricing of Vardenafil Hydrochloride? A: The generic drug market is highly competitive, leading to potential price erosion. However, the pricing of Vardenafil Hydrochloride can remain stable due to growing demand and overall market growth[3].

Q: What role do regulatory transparency initiatives play in drug pricing? A: Regulatory transparency initiatives, such as the Oregon Prescription Drug Price Transparency Act, provide accountability by disclosing pricing information, which can impact pricing strategies and consumer trust[2].

Q: How can pharmaceutical companies leverage NDC data for marketing purposes? A: Pharmaceutical companies can use NDC data to gain insights into market trends, patient preferences, and prescribing patterns, helping them develop targeted marketing strategies and optimize pricing[1].

Q: What are the projected growth trends for the US pharmaceutical market? A: The US pharmaceutical market is expected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%[4].

Sources

  1. Quality Smart Solutions: "Why NDC Numbers are vital for pharmaceutical companies?"
  2. Oregon Department of Consumer and Business Services: "Prescription Drug Price Transparency Annual Report 2022"
  3. S&P Global: "Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures"
  4. GlobeNewswire: "US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030"
  5. NDC List: "NDC Package 0527-2803-32 Vardenafil Hydrochloride Tablet Oral"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.